FIELD: medicine. SUBSTANCE: method involves introducing ЛАК-LAC-cells after surgical removal of tumor substrate only, combining with lymphocyte application stimulated with tumor antigen in the presence of ИЛ-2. Then a series of subcutaneous injections of autologic immunostimulating factors produced by cultivating patient lymphocytes with tumor antigen in ИЛ-2 presence. EFFECT: enhanced effectiveness of treatment. 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
METHOD FOR APPLYING VACCINE THERAPY FOR TREATING ONCOLOGIC DISEASES | 2000 |
|
RU2192883C2 |
DIAGNOSTIC TECHNIQUE FOR CEREBRAL GLIOBLASTOMA | 2010 |
|
RU2444732C1 |
VACCINE FOR ANTITUMOR IMMUNITY STIMULATION | 2000 |
|
RU2192884C2 |
METHOD FOR TREATING MALIGNANT CEREBRAL TUMORS BY APPLYING PHOTODYNAMIC LASER THERAPY | 2001 |
|
RU2214293C2 |
METHOD FOR DETERMINING A SURVIVAL PREDICTION OF PATIENTS WITH BRAIN GLIOMAS GRADE 2-GRADE 4 | 2019 |
|
RU2740481C2 |
METHOD FOR TREATING MALIGNANT BRAIN TUMORS | 2000 |
|
RU2192263C2 |
METHOD FOR DELIVERING PHOTOSENSIBILIZER TO TUMOR TISSUE IN BRAIN | 2001 |
|
RU2225233C2 |
METHOD FOR CORRECTING GEOPHYSICAL ENVIRONMENT-FACTOR-DEPENDENT FUNCTIONAL DISORDERS AND DISEASES | 1999 |
|
RU2179868C2 |
Authors
Dates
2003-02-10—Published
2000-05-10—Filed